D
Solid Biosciences Inc. SLDB
$5.20 -$0.19-3.53% NASDAQ
Recommendation
Prev Close
$5.39
Volume
1,734,292
Avg Vol (90D)
1,216,466
Market Cap
$419.71M
Dividend & Yield
--
52-Week Range
$2.41 - $7.37
P/E (TTM)
--
EPS (TTM)
-$2.80
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Brutal 2025 for Sarepta—Analysts Still Call for 179% Upside
8/12/2025 - MarketBeat
Solid Biosciences Reports Positive Interim Data on SGT-003
11/3/2025 - TipRanks Financial Blog
Solid Biosciences (SLDB) Reports Promising Interim Data on Duchenne Therapy
11/3/2025 - GuruFocus
Solid Biosciences Reports Third Quarter 2025 Financial Results and Provides Update on INSPIRE ...
11/3/2025 - GuruFocus
Solid Biosciences reports Q3 EPS (48c), consensus (44c)
11/3/2025 - The Fly
Solid Biosciences Reports Third Quarter 2025 Financial Results and Provides Update on INSPIRE DUCHENNE Clinical Trial Progress and Planned Regulatory Discussions
11/3/2025 - Globe Newswire
Solid Biosciences to Participate at Upcoming Investor Conferences
10/30/2025 - GuruFocus
Solid Biosciences to Participate at Upcoming Investor Conferences
10/30/2025 - Globe Newswire
Brokerages Set Solid Biosciences Inc. (NASDAQ:SLDB) Target Price at $15.00
10/27/2025 - Ticker Report
Weiss Ratings Reaffirms "Sell (D-)" Rating for Solid Biosciences (NASDAQ:SLDB)
10/26/2025 - MarketBeat
Solid Biosciences (NASDAQ:SLDB) Insider Sells $17,254.20 in Stock
10/24/2025 - Ticker Report
Solid Biosciences Inc. (NASDAQ:SLDB) Receives Consensus Rating of "Moderate Buy" from Brokerages
10/24/2025 - MarketBeat
We're Keeping An Eye On Solid Biosciences' (NASDAQ:SLDB) Cash Burn Rate
10/23/2025 - Simply Wall St
Solid Biosciences (SLDB, $5.64) Moving Average Convergence Divergence (MACD) Histogram turned negative on October 22, 2025
10/23/2025 - Tickeron - Stocks
Solid Biosciences (SLDB, $5.64) entered Downtrend as Momentum indicator drops below 0 level on Oct 22, 2025
10/23/2025 - Tickeron - Stocks
Gabriel Brooks Sells 2,895 Shares of Solid Biosciences (NASDAQ:SLDB) Stock
10/21/2025 - MarketBeat
Solid Biosciences (SLDB, $6.15) entered Uptrend as Momentum indicator ascends above 0 level on Oct 20, 2025
10/21/2025 - Tickeron - Stocks
Solid Biosciences (NASDAQ:SLDB) Downgraded by Wall Street Zen to "Sell"
10/20/2025 - Ticker Report
Solid Biosciences (NASDAQ:SLDB) Cut to Sell at Wall Street Zen
10/19/2025 - MarketBeat
Solid Biosciences (SLDB, $5.88) entered Downtrend as Momentum indicator drops below 0 level on Oct 17, 2025
10/18/2025 - Tickeron - Stocks
Solid Biosciences (SLDB, $5.88) Aroon Indicator entered an Uptrend on October 17, 2025.
10/18/2025 - Tickeron - Stocks
DCOR's Underlying Holdings Could Mean 13% Gain Potential
10/17/2025 - ETF Channel
Solid Biosciences (SLDB, $6.16) Aroon Indicator entered an Uptrend on October 16, 2025.
10/17/2025 - Tickeron - Technical Analysis
Solid Biosciences (SLDB, $6.32) Aroon Indicator entered an Uptrend on October 15, 2025.
10/16/2025 - Tickeron - Stocks
Sarepta Drops 42% on Fatalities; Markets Eye Solid Biosciences
6/18/2025 - MarketBeat
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
-$155.14M
EBIT (TTM)
-$156.82M
Net Income (TTM)
-$154.08M
Balance Sheet
Total Assets (Q)
$308.29M
Total Debt (Q)
$23.05M
Total Liabilities (Q)
$50.00M
Book Value Per Share (Q)
$3.33
Cash Flow
Cash from Operations (TTM)
-$122.62M
Cash from Investing (TTM)
-$32.62M
Cash from Financing (TTM)
$198.32M
Net Change in Cash (TTM)
$43.09M
Filings
Filing Date
Tuesday, August 12, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Nov 3 and 7 (est)
Price History
Loading...
Beta
1.64
7-Day Total Return
-5.80%
30-Day Total Return
0.58%
60-Day Total Return
-17.33%
90-Day Total Return
8.11%
Year to Date Total Return
33.33%
1-Year Total Return
-9.57%
2-Year Total Return
121.28%
3-Year Total Return
-17.46%
5-Year Total Return
-89.13%
52-week Low
May 15, 2025 - $2.41
52-week High
Jul 30, 2025 - $7.37
Valuation
Market Cap
$419.71M - Small Cap
Enterprise Value
$174.66M
Price/Sales (TTM)
--
Price/Book (Q)
1.62
Dividends and Shares
Shares Outstanding
94.14
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.solidbio.com
Phone Number
617 337 4680
Address
500 Rutherford Avenue
Charlestown, MA 02129
Country
United States
Year Founded
2013
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Solid Biosciences Inc. develops therapies for neuromuscular and cardiac diseases in the United States. The company’s lead product candidate is SGT-003, which is in phase 1/2 for the treatment of... more
NASDAQ 11/03/2025 4:00PM Eastern Quotes delayed